Reformulary Group announces Cannabis Standard, Canada’s first evidence-based medical cannabis formulary

X

Amber Mac's Dx3 2016 Tech Spotlight Interview with CEO Helen Stevenson of Reformulary Group

Jun 03, 2016

Amber Mac's Dx3 2016 Tech Spotlight Interview with CEO Helen Stevenson of Reformulary Group

Related News

placeholder
May 21, 2019
Letter to the editor: Pharmacare – not all Canadians, not al...
 
Learn More
placeholder
May 02, 2019
The challenges with medical cannabis in the workplace
 
Learn More
placeholder
Apr 24, 2019
Reformulary Group creates online community platform for info...
 
Learn More
See all news
×